APO Research
Talk to an analyst

APO RESEARCH · REPORT

Induced Pluripotent Stem Cells (iPSCs)

Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.

Selected research

Market Structure

Global Induced Pluripotent Stem Cells (iPSCs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025183 pages

Choose your research edition.

Industry ResearchInduced Pluripotent Stem Cells (iPSCs) Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Induced Pluripotent Stem Cells (iPSCs) Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Induced Pluripotent Stem Cells (iPSCs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Induced Pluripotent Stem Cells (iPSCs) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Induced Pluripotent Stem Cells (iPSCs) Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

Induced pluripotent stem cells (also known as iPS cells or iPSCs) are a type of pluripotent stem cell that can be generated directly from adult cells. The opportunities concerning a wide range of diseases including neurodegenerative, metabolic and cardiovascular diseases in a dish for cheaper and faster drug discovery. This may be particularly important in the context of monogenic rare hereditary diseases, where iPSCs can provide an alternative model system to compensate for the lack of a predictive in-vitro human model for drug discovery.

United States is the largest Induced Pluripotent Stem Cells (iPSCs) market with about 43% market share. Europe is follower, accounting for about 33% market share.

The key players are Fujifilm Holding Corporation (CDI), Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL etc. Top 3 companies occupied about 73% market share.

Read the full market overview

Report Includes

This report provides an overview of the global Induced Pluripotent Stem Cells (iPSCs) market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Induced Pluripotent Stem Cells (iPSCs) and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Induced Pluripotent Stem Cells (iPSCs) revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Induced Pluripotent Stem Cells (iPSCs) market size, projected growth trends, production technologies, key applications, and end-use industries.

Induced Pluripotent Stem Cells (iPSCs) Segment by Company

Fujifilm Holding Corporation (CDI)

Ncardia

Sumitomo Dainippon Pharma

Astellas Pharma Inc

Fate Therapeutics, Inc

Pluricell Biotech

Cell Inspire Biotechnology

ReproCELL

Induced Pluripotent Stem Cells (iPSCs) Segment by Type

Human iPSCs

Mouse iPSCs

Induced Pluripotent Stem Cells (iPSCs) Segment by Application

Academic Research

Drug Development and Discovery

Toxicity Screening

Regenerative Medicine

Others

Induced Pluripotent Stem Cells (iPSCs) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Induced Pluripotent Stem Cells (iPSCs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Induced Pluripotent Stem Cells (iPSCs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Induced Pluripotent Stem Cells (iPSCs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Induced Pluripotent Stem Cells (iPSCs) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Induced Pluripotent Stem Cells (iPSCs) industry.

Chapter 3: Detailed analysis of Induced Pluripotent Stem Cells (iPSCs) companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Induced Pluripotent Stem Cells (iPSCs)revenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Human iPSCs Table 3. Key Players of Mouse iPSCs Table 4. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Academic Research Table 6. Key Players of Drug Development and Discovery Table 7. Key Players of Toxicity Screening Table 8. Key Players of Regenerative Medicine Table 9. Key Players of Others Table 10. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2021-2026) Table 13. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Region (2027-2032) Table 15. Induced Pluripotent Stem Cells (iPSCs) Industry Trends Table 16. Induced Pluripotent Stem Cells (iPSCs) Industry Drivers Table 17. Induced Pluripotent Stem Cells (iPSCs) Industry Opportunities and Challenges Table 18. Induced Pluripotent Stem Cells (iPSCs) Industry Restraints Table 19. Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Company (2021-2026) Table 21. Global Induced Pluripotent Stem Cells (iPSCs) Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Induced Pluripotent Stem Cells (iPSCs) Key Company Head Office and Area Served Table 23. Global Induced Pluripotent Stem Cells (iPSCs) Company, Product Type & Application Table 24. Global Induced Pluripotent Stem Cells (iPSCs) Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Induced Pluripotent Stem Cells (iPSCs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2021-2026) Table 31. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2027-2032) Table 32. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2021-2026) Table 36. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2027-2032) Table 37. Fujifilm Holding Corporation (CDI) Company Information Table 38. Fujifilm Holding Corporation (CDI) Business Overview Table 39. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Portfolio Table 41. Fujifilm Holding Corporation (CDI) Recent Development Table 42. Ncardia Company Information Table 43. Ncardia Business Overview Table 44. Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Portfolio Table 46. Ncardia Recent Development Table 47. Sumitomo Dainippon Pharma Company Information Table 48. Sumitomo Dainippon Pharma Business Overview Table 49. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Portfolio Table 51. Sumitomo Dainippon Pharma Recent Development Table 52. Astellas Pharma Inc Company Information Table 53. Astellas Pharma Inc Business Overview Table 54. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Portfolio Table 56. Astellas Pharma Inc Recent Development Table 57. Fate Therapeutics, Inc Company Information Table 58. Fate Therapeutics, Inc Business Overview Table 59. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Portfolio Table 61. Fate Therapeutics, Inc Recent Development Table 62. Pluricell Biotech Company Information Table 63. Pluricell Biotech Business Overview Table 64. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Portfolio Table 66. Pluricell Biotech Recent Development Table 67. Cell Inspire Biotechnology Company Information Table 68. Cell Inspire Biotechnology Business Overview Table 69. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Portfolio Table 71. Cell Inspire Biotechnology Recent Development Table 72. ReproCELL Company Information Table 73. ReproCELL Business Overview Table 74. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Portfolio Table 76. ReproCELL Recent Development Table 77. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026) & (US$ Million) Table 78. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2027-2032) & (US$ Million) Table 79. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026) & (US$ Million) Table 80. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2027-2032) & (US$ Million) Table 81. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026) Table 83. North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2027-2032) Table 84. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026) & (US$ Million) Table 85. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2027-2032) & (US$ Million) Table 86. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026) & (US$ Million) Table 87. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2027-2032) & (US$ Million) Table 88. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026) Table 90. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2027-2032) Table 91. China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026) & (US$ Million) Table 92. China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2027-2032) & (US$ Million) Table 93. China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026) & (US$ Million) Table 94. China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2027-2032) & (US$ Million) Table 95. Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026) & (US$ Million) Table 96. Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2027-2032) & (US$ Million) Table 97. Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026) & (US$ Million) Table 98. Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2027-2032) & (US$ Million) Table 99. Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026) Table 101. Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2027-2032) Table 102. South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026) & (US$ Million) Table 103. South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2027-2032) & (US$ Million) Table 104. South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026) & (US$ Million) Table 105. South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2027-2032) & (US$ Million) Table 106. South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026) Table 108. South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2027-2032) Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Induced Pluripotent Stem Cells (iPSCs) Product Image Figure 2. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Type: 2025 VS 2032 Figure 4. Human iPSCs Image Figure 5. Mouse iPSCs Image Figure 6. Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Application: 2025 VS 2032 Figure 8. Academic Research Image Figure 9. Drug Development and Discovery Image Figure 10. Toxicity Screening Image Figure 11. Regenerative Medicine Image Figure 12. Others Image Figure 13. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 15. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Induced Pluripotent Stem Cells (iPSCs) Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Induced Pluripotent Stem Cells (iPSCs) Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Type (2021-2032) Figure 22. Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Induced Pluripotent Stem Cells (iPSCs) Revenue Market Share by Application (2021-2032) Figure 24. North America Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 25. North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2021-2032) Figure 26. North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2021-2032) Figure 27. North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2021-2032) Figure 28. United States Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 29. Canada Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 31. Europe Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 32. Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2021-2032) Figure 33. Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2021-2032) Figure 34. Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2021-2032) Figure 35. Germany Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 36. France Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 38. Italy Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 39. Russia Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 41. China Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 42. China Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2021-2032) Figure 43. China Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2021-2032) Figure 44. Asia Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 45. Asia Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2021-2032) Figure 46. Asia Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2021-2032) Figure 47. Asia Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2021-2032) Figure 48. Japan Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 52. India Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 53. Australia Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2021-2032) Figure 58. Brazil Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 63. UAE Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 65. Chile Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Human iPSCs
  • Mouse iPSCs
Applications
  • Academic Research
  • Drug Development and Discovery
  • Toxicity Screening
  • Regenerative Medicine
  • Others
Companies covered
  • Fujifilm Holding Corporation (CDI)
  • Ncardia
  • Sumitomo Dainippon Pharma
  • Astellas Pharma Inc
  • Fate Therapeutics, Inc
  • Pluricell Biotech
  • Cell Inspire Biotechnology
  • ReproCELL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Human iPSCs
  5. 1.2.3 Mouse iPSCs
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Academic Research
  9. 1.3.3 Drug Development and Discovery
  10. 1.3.4 Toxicity Screening
  11. 1.3.5 Regenerative Medicine
  12. 1.3.6 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Induced Pluripotent Stem Cells (iPSCs) Growth Trends by Region
  15. 1.5.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2021-2026)
  17. 1.5.3 Induced Pluripotent Stem Cells (iPSCs) Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Induced Pluripotent Stem Cells (iPSCs) Market Dynamics
  1. 2.1 Induced Pluripotent Stem Cells (iPSCs) Industry Trends
  2. 2.2 Induced Pluripotent Stem Cells (iPSCs) Industry Drivers
  3. 2.3 Induced Pluripotent Stem Cells (iPSCs) Industry Opportunities and Challenges
  4. 2.4 Induced Pluripotent Stem Cells (iPSCs) Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Induced Pluripotent Stem Cells (iPSCs) Revenue by Company (2021-2026)
  2. 3.2 Global Induced Pluripotent Stem Cells (iPSCs) Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Induced Pluripotent Stem Cells (iPSCs) Key Company Head office and Area Served
  4. 3.4 Global Induced Pluripotent Stem Cells (iPSCs) Company, Product Type & Application
  5. 3.5 Global Induced Pluripotent Stem Cells (iPSCs) Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Induced Pluripotent Stem Cells (iPSCs) Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Induced Pluripotent Stem Cells (iPSCs) Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Induced Pluripotent Stem Cells (iPSCs) Tier 1, Tier 2, and Tier 3
4 Induced Pluripotent Stem Cells (iPSCs) Market by Type
  1. 4.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2032)
  3. 4.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Type (2021-2032)
5 Induced Pluripotent Stem Cells (iPSCs) Market by Application
  1. 5.1 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2032)
  3. 5.3 Global Induced Pluripotent Stem Cells (iPSCs) Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Fujifilm Holding Corporation (CDI)
  2. 6.1.1 Fujifilm Holding Corporation (CDI) Company Information
  3. 6.1.2 Fujifilm Holding Corporation (CDI) Business Overview
  4. 6.1.3 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Fujifilm Holding Corporation (CDI) Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
  6. 6.1.5 Fujifilm Holding Corporation (CDI) Recent Developments
  7. 6.2 Ncardia
  8. 6.2.1 Ncardia Company Information
  9. 6.2.2 Ncardia Business Overview
  10. 6.2.3 Ncardia Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Ncardia Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
  12. 6.2.5 Ncardia Recent Developments
  13. 6.3 Sumitomo Dainippon Pharma
  14. 6.3.1 Sumitomo Dainippon Pharma Company Information
  15. 6.3.2 Sumitomo Dainippon Pharma Business Overview
  16. 6.3.3 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sumitomo Dainippon Pharma Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
  18. 6.3.5 Sumitomo Dainippon Pharma Recent Developments
  19. 6.4 Astellas Pharma Inc
  20. 6.4.1 Astellas Pharma Inc Company Information
  21. 6.4.2 Astellas Pharma Inc Business Overview
  22. 6.4.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Astellas Pharma Inc Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
  24. 6.4.5 Astellas Pharma Inc Recent Developments
  25. 6.5 Fate Therapeutics, Inc
  26. 6.5.1 Fate Therapeutics, Inc Company Information
  27. 6.5.2 Fate Therapeutics, Inc Business Overview
  28. 6.5.3 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Fate Therapeutics, Inc Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
  30. 6.5.5 Fate Therapeutics, Inc Recent Developments
  31. 6.6 Pluricell Biotech
  32. 6.6.1 Pluricell Biotech Company Information
  33. 6.6.2 Pluricell Biotech Business Overview
  34. 6.6.3 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Pluricell Biotech Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
  36. 6.6.5 Pluricell Biotech Recent Developments
  37. 6.7 Cell Inspire Biotechnology
  38. 6.7.1 Cell Inspire Biotechnology Company Information
  39. 6.7.2 Cell Inspire Biotechnology Business Overview
  40. 6.7.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
  42. 6.7.5 Cell Inspire Biotechnology Recent Developments
  43. 6.8 ReproCELL
  44. 6.8.1 ReproCELL Company Information
  45. 6.8.2 ReproCELL Business Overview
  46. 6.8.3 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 ReproCELL Induced Pluripotent Stem Cells (iPSCs) Product Portfolio
  48. 6.8.5 ReproCELL Recent Developments
7 North America
  1. 7.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032)
  2. 7.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
  3. 7.2.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026)
  4. 7.2.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2027-2032)
  5. 7.2.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2021-2032)
  6. 7.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
  7. 7.3.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026)
  8. 7.3.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2027-2032)
  9. 7.3.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2021-2032)
  10. 7.4 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
  11. 7.4.1 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026)
  13. 7.4.3 North America Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2027-2032)
  14. 7.4.4 North America Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032)
  2. 8.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
  3. 8.2.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026)
  4. 8.2.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2027-2032)
  5. 8.2.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2021-2032)
  6. 8.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
  7. 8.3.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026)
  8. 8.3.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2027-2032)
  9. 8.3.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2021-2032)
  10. 8.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
  11. 8.4.1 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026)
  13. 8.4.3 Europe Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2027-2032)
  14. 8.4.4 Europe Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032)
  2. 9.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
  3. 9.2.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026)
  4. 9.2.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2027-2032)
  5. 9.2.3 China Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2021-2032)
  6. 9.3 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
  7. 9.3.1 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026)
  8. 9.3.2 China Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2027-2032)
  9. 9.3.3 China Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032)
  2. 10.2 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
  3. 10.2.1 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026)
  4. 10.2.2 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2027-2032)
  5. 10.2.3 Asia Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2021-2032)
  6. 10.3 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
  7. 10.3.1 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026)
  8. 10.3.2 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2027-2032)
  9. 10.3.3 Asia Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2021-2032)
  10. 10.4 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
  11. 10.4.1 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026)
  13. 10.4.3 Asia Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2027-2032)
  14. 10.4.4 Asia Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Induced Pluripotent Stem Cells (iPSCs) Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst